Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-31

Clinical Trial Update: Artemether-lumefantrine (AL) Versus Artesunate + Amodiaquine (ASAQ) for the Treatment of Uncomplicated Falciparum Malaria in Burkina Faso [Phase 4]

View source ↗

Summary

Phase 4 trial comparing artemether-lumefantrine (AL) with artesunate–amodiaquine (ASAQ) for treating uncomplicated Plasmodium falciparum malaria in children in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASAQ (amodiaquine-artesunate)
  • Coartem (artemether-lumefantrine)

Snippet

Sponsor: Centre Muraz | Conditions: Uncomplicated P. Falciparum Malaria in Children | Phase 4 | Status: COMPLETED